Concepts (144)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Macular Degeneration | 11 | 2023 | 981 | 2.900 |
Why?
|
| Dark Adaptation | 4 | 2021 | 217 | 2.480 |
Why?
|
| Metabolomics | 6 | 2023 | 1487 | 1.760 |
Why?
|
| Wet Macular Degeneration | 4 | 2019 | 145 | 1.680 |
Why?
|
| Choroid | 5 | 2022 | 322 | 1.370 |
Why?
|
| Retinal Drusen | 3 | 2021 | 66 | 0.940 |
Why?
|
| Retinal Necrosis Syndrome, Acute | 1 | 2022 | 21 | 0.840 |
Why?
|
| Vision, Monocular | 1 | 2022 | 74 | 0.820 |
Why?
|
| Choroidal Neovascularization | 3 | 2022 | 343 | 0.790 |
Why?
|
| Retinal Detachment | 2 | 2022 | 411 | 0.780 |
Why?
|
| Tomography, Optical Coherence | 12 | 2023 | 2657 | 0.770 |
Why?
|
| Optic Neuropathy, Ischemic | 1 | 2021 | 73 | 0.760 |
Why?
|
| Vision, Binocular | 1 | 2022 | 209 | 0.760 |
Why?
|
| Geographic Atrophy | 2 | 2019 | 66 | 0.730 |
Why?
|
| Retinal Rod Photoreceptor Cells | 1 | 2021 | 195 | 0.710 |
Why?
|
| Diabetic Retinopathy | 5 | 2022 | 1211 | 0.690 |
Why?
|
| Visual Acuity | 9 | 2021 | 2525 | 0.600 |
Why?
|
| Body Fluids | 1 | 2019 | 319 | 0.590 |
Why?
|
| Carotid Artery Diseases | 1 | 2021 | 875 | 0.510 |
Why?
|
| Vitreous Body | 3 | 2022 | 389 | 0.470 |
Why?
|
| Retinal Diseases | 2 | 2019 | 685 | 0.450 |
Why?
|
| Uveal Neoplasms | 1 | 2016 | 310 | 0.450 |
Why?
|
| Retina | 3 | 2019 | 2612 | 0.450 |
Why?
|
| Metabolome | 2 | 2023 | 894 | 0.440 |
Why?
|
| Macular Edema | 3 | 2022 | 359 | 0.400 |
Why?
|
| Lipids | 2 | 2018 | 3307 | 0.350 |
Why?
|
| Cross-Sectional Studies | 15 | 2023 | 25032 | 0.330 |
Why?
|
| Neoplasms, Second Primary | 1 | 2016 | 1063 | 0.310 |
Why?
|
| Fluorescein Angiography | 6 | 2022 | 940 | 0.270 |
Why?
|
| Delivery of Health Care | 1 | 2023 | 5319 | 0.260 |
Why?
|
| Physicians | 1 | 2023 | 4569 | 0.260 |
Why?
|
| Diagnostic Techniques, Ophthalmological | 2 | 2018 | 245 | 0.260 |
Why?
|
| Macula Lutea | 1 | 2023 | 151 | 0.210 |
Why?
|
| Prospective Studies | 11 | 2022 | 53250 | 0.210 |
Why?
|
| Retinal Vein Occlusion | 1 | 2023 | 137 | 0.210 |
Why?
|
| Aged | 21 | 2023 | 163178 | 0.200 |
Why?
|
| Polyps | 1 | 2022 | 189 | 0.190 |
Why?
|
| Angiogenesis Inhibitors | 3 | 2021 | 2037 | 0.180 |
Why?
|
| Ciliary Arteries | 1 | 2019 | 17 | 0.170 |
Why?
|
| Carotid Artery, Internal | 1 | 2021 | 445 | 0.170 |
Why?
|
| Empathy | 1 | 2023 | 474 | 0.170 |
Why?
|
| Retinal Telangiectasis | 1 | 2019 | 24 | 0.170 |
Why?
|
| Middle Aged | 17 | 2021 | 213241 | 0.160 |
Why?
|
| Aged, 80 and over | 9 | 2019 | 57744 | 0.160 |
Why?
|
| Humans | 33 | 2023 | 743811 | 0.160 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2019 | 3758 | 0.150 |
Why?
|
| Lenses, Intraocular | 1 | 2019 | 140 | 0.150 |
Why?
|
| Choroid Diseases | 1 | 2018 | 66 | 0.150 |
Why?
|
| Female | 22 | 2022 | 380020 | 0.150 |
Why?
|
| Melanoma | 1 | 2016 | 5508 | 0.150 |
Why?
|
| Male | 22 | 2022 | 349776 | 0.150 |
Why?
|
| Area Under Curve | 1 | 2021 | 1654 | 0.150 |
Why?
|
| Specialty Boards | 1 | 2018 | 227 | 0.140 |
Why?
|
| Visual Field Tests | 1 | 2019 | 379 | 0.140 |
Why?
|
| Phacoemulsification | 1 | 2018 | 148 | 0.140 |
Why?
|
| Lens Implantation, Intraocular | 1 | 2018 | 192 | 0.140 |
Why?
|
| Life Style | 2 | 2018 | 3833 | 0.140 |
Why?
|
| Endophthalmitis | 1 | 2019 | 262 | 0.140 |
Why?
|
| Eye Infections, Bacterial | 1 | 2019 | 235 | 0.140 |
Why?
|
| Sensory Thresholds | 1 | 2017 | 391 | 0.130 |
Why?
|
| Drug Substitution | 1 | 2018 | 281 | 0.130 |
Why?
|
| Portugal | 3 | 2019 | 86 | 0.130 |
Why?
|
| Retinal Pigment Epithelium | 1 | 2018 | 302 | 0.130 |
Why?
|
| Photography | 1 | 2018 | 519 | 0.130 |
Why?
|
| Vision Disorders | 2 | 2019 | 1055 | 0.120 |
Why?
|
| Perioperative Care | 2 | 2019 | 1002 | 0.120 |
Why?
|
| Intravitreal Injections | 3 | 2019 | 344 | 0.110 |
Why?
|
| Cataract | 1 | 2019 | 834 | 0.110 |
Why?
|
| Visual Fields | 1 | 2019 | 1041 | 0.100 |
Why?
|
| Retinal Vessels | 1 | 2017 | 772 | 0.100 |
Why?
|
| Diet, Mediterranean | 1 | 2018 | 700 | 0.100 |
Why?
|
| Dexamethasone | 1 | 2018 | 1950 | 0.090 |
Why?
|
| SEER Program | 1 | 2016 | 1507 | 0.090 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2019 | 3510 | 0.090 |
Why?
|
| Medicine | 1 | 2018 | 945 | 0.090 |
Why?
|
| Mass Spectrometry | 1 | 2017 | 2203 | 0.090 |
Why?
|
| Health Personnel | 1 | 2023 | 3217 | 0.090 |
Why?
|
| Follow-Up Studies | 3 | 2021 | 39001 | 0.090 |
Why?
|
| Anxiety | 1 | 2023 | 4288 | 0.080 |
Why?
|
| Bacteria | 1 | 2019 | 2112 | 0.080 |
Why?
|
| Rural Population | 1 | 2018 | 2207 | 0.080 |
Why?
|
| Patient Compliance | 1 | 2018 | 2683 | 0.080 |
Why?
|
| Population Surveillance | 1 | 2018 | 2614 | 0.080 |
Why?
|
| Incidence | 4 | 2019 | 20948 | 0.070 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2022 | 11729 | 0.070 |
Why?
|
| Case-Control Studies | 3 | 2018 | 21733 | 0.070 |
Why?
|
| Risk Factors | 5 | 2022 | 72252 | 0.070 |
Why?
|
| Alcohol Drinking | 1 | 2018 | 3965 | 0.060 |
Why?
|
| Genome-Wide Association Study | 1 | 2023 | 12259 | 0.060 |
Why?
|
| Comorbidity | 1 | 2018 | 10380 | 0.060 |
Why?
|
| Logistic Models | 1 | 2018 | 13404 | 0.060 |
Why?
|
| Chronic Disease | 1 | 2018 | 9139 | 0.060 |
Why?
|
| Clinical Competence | 1 | 2018 | 4687 | 0.050 |
Why?
|
| Contrast Sensitivity | 1 | 2023 | 242 | 0.050 |
Why?
|
| Proportional Hazards Models | 1 | 2016 | 12354 | 0.050 |
Why?
|
| Retrospective Studies | 6 | 2022 | 77410 | 0.050 |
Why?
|
| Phenotype | 1 | 2018 | 16361 | 0.050 |
Why?
|
| Databases, Factual | 1 | 2016 | 7729 | 0.050 |
Why?
|
| Anti-Bacterial Agents | 1 | 2019 | 7172 | 0.050 |
Why?
|
| Body Mass Index | 1 | 2018 | 12718 | 0.050 |
Why?
|
| Eye, Artificial | 1 | 2019 | 18 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2017 | 15526 | 0.040 |
Why?
|
| Statistical Distributions | 1 | 2018 | 64 | 0.040 |
Why?
|
| Internship and Residency | 1 | 2018 | 5787 | 0.040 |
Why?
|
| Albuminuria | 1 | 2022 | 681 | 0.040 |
Why?
|
| Angiography | 1 | 2023 | 1638 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2019 | 40545 | 0.040 |
Why?
|
| Drug Implants | 1 | 2018 | 241 | 0.040 |
Why?
|
| Indocyanine Green | 1 | 2019 | 240 | 0.040 |
Why?
|
| Ocular Hypertension | 1 | 2018 | 198 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2018 | 23327 | 0.040 |
Why?
|
| Fundus Oculi | 1 | 2017 | 473 | 0.030 |
Why?
|
| Coloring Agents | 1 | 2019 | 565 | 0.030 |
Why?
|
| Postoperative Complications | 1 | 2018 | 15281 | 0.030 |
Why?
|
| Bayes Theorem | 1 | 2023 | 2307 | 0.030 |
Why?
|
| Triglycerides | 1 | 2022 | 2453 | 0.030 |
Why?
|
| Infant | 1 | 2016 | 35122 | 0.030 |
Why?
|
| Postoperative Period | 1 | 2018 | 1841 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2016 | 40964 | 0.030 |
Why?
|
| Cholesterol | 1 | 2022 | 2922 | 0.030 |
Why?
|
| Age Distribution | 1 | 2019 | 2899 | 0.030 |
Why?
|
| Intraocular Pressure | 1 | 2018 | 1269 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 2019 | 1962 | 0.030 |
Why?
|
| Drug Resistance | 1 | 2018 | 1606 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2018 | 2617 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 35409 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2018 | 4931 | 0.020 |
Why?
|
| Antihypertensive Agents | 1 | 2018 | 2047 | 0.020 |
Why?
|
| Glucocorticoids | 1 | 2018 | 2107 | 0.020 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2018 | 2281 | 0.020 |
Why?
|
| Prognosis | 2 | 2019 | 29052 | 0.020 |
Why?
|
| United States | 1 | 2016 | 69859 | 0.020 |
Why?
|
| Child | 1 | 2016 | 77637 | 0.020 |
Why?
|
| Adolescent | 1 | 2016 | 85729 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2019 | 10940 | 0.020 |
Why?
|
| Animals | 1 | 2018 | 168660 | 0.020 |
Why?
|
| Adult | 2 | 2018 | 213889 | 0.020 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2017 | 4033 | 0.010 |
Why?
|
| Disease Progression | 1 | 2019 | 13273 | 0.010 |
Why?
|
| Prevalence | 1 | 2018 | 15211 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 19894 | 0.010 |
Why?
|
| Inflammation | 1 | 2018 | 10629 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2019 | 63042 | 0.010 |
Why?
|
| Young Adult | 1 | 2018 | 56392 | 0.010 |
Why?
|
Concepts
(144)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(37)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_